Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.
Khan HY, Al Hallak MN, Aboukameel A, Bannoura SF, Uddin MH, Aboukameel AA, Alkan FK, Caglayan AB, Alkan HK, Bao B, Jimenez H, Johansen AM, McGrath C, Barker G, Choucair K, Tubon M, Beal E, Kim S, Beydoun R, Dyson G, Shi Y, Nagasaka M, Atfi A, Korkaya H, Saif MW, Philip PA, El-Rayes B, Chen H, Shields AF, Mohammad RM, Pasche BC, Azmi AS.
Khan HY, et al. Among authors: aboukameel a, aboukameel aa.
bioRxiv [Preprint]. 2025 Nov 25:2025.11.21.689857. doi: 10.1101/2025.11.21.689857.
bioRxiv. 2025.
PMID: 41394580
Free PMC article.
Preprint.